Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

GH Guardant Health Inc

33,40

1,63 (5,13%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/13/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

08/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Meghan V. Joyce

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Guardant Health (NASDAQ:GH)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Guardant Health Charts.

Guardant Health (NASDAQ:GH)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Guardant Health Charts.

News Guardant Health Inc

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (4 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (1 Tag vor) • Edgar (US Regulatory)

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Donnerstag 2 Januar 2025 (1 Tag vor) • Business Wire

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
Freitag 20 Dezember 2024 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
Donnerstag 19 Dezember 2024 (2 Wochen vor) • Business Wire

Weitere Guardant Health Inc News-Artikel

Deutsche Lufthansa

JP Morgan Chase

Financial Select Sector

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen